BHVN: Biohaven Ltd

15.24 USD 1.82 (13.56%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de BHVN a changé de 13.56% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 13.42 et à un maximum de 16.00.

Suivez la dynamique Biohaven Ltd. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

BHVN Nouvelles

Benzinga 14:47 Teradyne, Littelfuse, Marvell Technology, Cheesecake Factory And Other Big Stocks Moving Higher On Wednesday - Biohaven (NYSE:BHVN), Ashland (NYSE:ASH)
Investing 14:31 Fortress Transport, Teradyne lead market cap stock movers on Wednesday
Investing 19:34 Biohaven stock hits 52-week low at $13.03 amid challenging year
Seeking Alpha 07:54 Biohaven Stock: Cash Hog Awaits FDA Decision On SCA (NYSE:BHVN)
Investing 14:38 Biohaven Pharmaceutical stock hits 52-week low at 13.68 USD
Investing 18:22 Biohaven stock hits 52-week low at $13.86
TipRanks 12:00 3 Best Stocks to Buy Now, 6/19/2025, According to Top Analysts - TipRanks.com
Investing 13:32 Biohaven stock hits 52-week low at 14.32 USD
Investing 18:12 Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development
Investing 16:36 Biohaven stock hits 52-week low at $14.36 amid market challenges
Investing 11:32 H.C. Wainwright maintains Buy on Biohaven stock, $54 price target
Investing 15:46 Morgan Stanley maintains Biohaven stock with $63 target
Investing 12:18 Cowen reiterates Buy on Biohaven stock, maintains $75 target
Investing 11:14 Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson’s Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor
Investing 19:04 Biohaven’s BHV-1400 shows promise in IgA nephropathy treatment
Investing 11:37 Biohaven’s BHV-1510 shows promise in early cancer trial
Investor's Business Daily 13:06 IBD 50 Stock Travere Therapeutics Nosedived On An FDA Decision — Here's Why
Investor's Business Daily 18:06 Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug
Benzinga 17:22 Why Is Biohaven Stock Falling On Thursday? - Biohaven (NYSE:BHVN)
Investing 14:32 UnitedHealth, Alibaba lead market cap stock movers on Thursday
Benzinga 12:33 Red Cat Holdings, Alibaba, DXC Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Alibaba Gr Hldgs (NYSE:BABA), Biohaven (NYSE:BHVN)
Investing 22:56 FDA Extends PDUFA Date of Biohaven’s Troriluzole NDA for Rare Disease Spinocerebellar Ataxia
Benzinga 14:26 Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland - Biohaven (NYSE:BHVN)
Benzinga 12:49 Stride To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday - Biohaven (NYSE:BHVN), Banzai International (NASDAQ:BNZI)

Range quotidien

13.42 16.00

Range Annuel

12.80 55.70

Clôture Précédente: 12.83
Ouverture: 13.42

Bid: 15.24
Ask: 15.54

Plus Bas: 13.42
Plus Haut: 16.00

Volume: 7.878 K

Changement quotidien: 13.56%
Changement Mensuel: 8.78%

Changement à 6 Mois: -59.23%
Changement Annuel: -60.92%

30 juillet, mercredi